Opportunity to Improve Healthcare
Healthcare to Improve for Cannabis Patients
Cannabis patients comprise 1% of over 100 million US residents with qualifying conditions such as chronic pain, PTSD, cancer induced nausea and vomiting (CINV), cachexia, neurodegenerative disorders, seizure disorders, spasticity disorders, diabetes, HIV/AIDS, and glaucoma. This “therapeutic gap” exists in large part due to the lack of credible, clinically useful information about cannabis for patients and health care professionals. A 1% prescription rate for medical marijuana corresponds to the prescription rate observed in surveys of physicians practicing in specialties where cannabis is part of the treatment armamentaria. The fact that between 5-7% of surveyed physicians prescribed a synthetic cannabis analog quantifies the potential for broadening usage of medical cannabis.
420 InSight sees a historic opportunity to use health information to improve care for one million patients already using cannabis, and to increase access to medical cannabis as appropriate for all patients with qualifying conditions. Cannabis patients who have received their recommendations from HCPs with whom they have preexisting patient-doctor relationship to a person would like more and better health information about cannabis. Better information results in more appropriate treatment, better outcomes, and reduced drug costs for the cannabis patient.
There are 39 states and the District of Columbia with partial or full-fledged medical cannabis programs, containing
- 271 million residents (85% of US population, including 181 million >18 years of age)
- 2 million patients
- 120 million patients with qualifying conditions.
The Long Tail of the Green Rush
California became the first state with medical cannabis in 1996, and 22 states and the District of Columbia have approved or implemented programs through 2014. In states with medical cannabis, there are
- 1 million patients, 600,000 registered (90,000 registered in California voluntarily, estimated 500,000 total with marijuana recommendation from physician)
- 140 million adult residents
- 23 million adult residents suffering from arthritis and chronic joint pain
- Millions more with conditions treatable with medical marijuana, including cancer and HIV, epilepsy, PTSD and fibromyalgia.
In addition to the 23 states and District of Columbia, CBD oil extracted from high-CBD/low-THC strains of cannabis is legal in 16 states without a full-blown medical cannabis program. Ohio and Pennsylvania will decide whether or not to legalize medical cannabis in 2016.